E-Scape Bio
United States
About E-Scape Bio
E-scape Bio is a Californian company involved in the healthcare industry. The company was founded in 2015 and is headquartered in San Francisco, California.
YEAR FOUNDED:
2015
LEADERSHIP:
Executive Director: Mr. Leon Chen
7 articles about E-Scape Bio
-
E-Scape Bio Appoints Anthony Rimac as Chief Financial Officer and Ann Kapoun, Ph.D., as SVP of R&D
12/19/2019
E-Scape Bio, Inc., a clinical stage, privately held biopharmaceutical company developing novel, precisely-targeted therapeutics for genetically-defined neurodegenerative diseases, announced the appointment of Tony Rimac as Chief Financial Officer and Ann Kapoun, Ph.D., as SVP of R&D.
-
E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer
1/3/2019
E-Scape Bio has expanded its senior management team with the appointment of Carrolee Barlow, M.D., Ph.D., as chief medical officer, effective today.
-
Biotech Movers and Shakers Aug. 27
8/27/2018
Who made a splash in the biotech world this week? Here are some notable people. -
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
8/23/2018
E-Scape Bio announced the appointment of Julie Anne Smith as president and chief executive officer and member of the board of directors.
-
E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders
6/12/2018
E-Scape adds late pre-clinical program to pipeline of genetically defined programs to treat CNS disorders. AbbVie will become an investor in E-Scape.
-
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's
7/13/2017
-
Biogen Puts E-Scape Bio Vet on Payroll to Tackle Neurodegenerative Diseases Like Alzheimer's
3/16/2017